Prospective Cohort Study Of The Immune Response To Severe Acute Respiratory Coronavirus 2 (SARS-Cov2) In Oncology Workers: Protect Covid-19 Study
The main long-term goal of this proposal is to assess measures of immune activation after vaccination for SARS-CoV2 among oncology workers.
Note: The study population includes oncology workers from any health care institution in the state of Florida who is willing to come to Moffitt Cancer for study participation.
2.1 PRIMARY OBJECTIVE AND ENDPOINT
To assess measures of immune activation against SARS-CoV2 (longitudinally) in the study population which consists of vaccinated oncology workers.
Note: Longitudinal assessments of serum IgG titers and CD4+ (ELISPOT) immune response against SARS-CoV2 spike protein.
Note: Vaccinations will be conducted as part of standard of care and NOT as part of the study.
There are no interventions planned for this observational cohort study.
2.2 SECONDARY OBJECTIVES
1. To compare longitudinal measures of immune activation (i.e., serum IgG titers and CD4+[ELISPOT]) at baseline, 12 months, and 24 months.
2. To assess the absolute risk of Covid-19 infection among participants treated with SARSCoV2 during study period.
Note: Confirmed Covid-19 is defined according to the Food and Drug Administration
(FDA) criteria as the presence of at least one of the following symptoms: fever, new or
increased cough, new or increased shortness of breath, chills, new or increased muscle
pain, new loss of taste or smell, sore throat, diarrhea, or vomiting, combined with a
respiratory specimen obtained during the symptomatic period or within 4 days before or
after it that was positive for SARS-CoV-2 by nucleic acid amplification based testing.
3. To assess correlations between measures of immune activation against SARS-CoV2
and participant-associated characteristics (e.g., age, comorbidities, previous diagnosis of
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate button below. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub